Literature DB >> 7948159

Survival and medical intervention in southern Brazilian AIDS patients.

B Santos1, E J Beck, M F Peixoto.   

Abstract

The aim of the study was to describe survival patterns of Southern Brazilian AIDS patients: 224 predominantly working class AIDS patients were treated in an AIDS referral centre in Porto Alegre between October 1986 and September 1991. The caseload increased progressively, as did the number of female AIDS cases treated at the Hospital during the study period. Self-referred patients were more likely to present with an AIDS defining condition (P < 0.03) and they (n = 106) had significantly worse survival patterns compared with patients referred by other health care professionals (n = 112; P < 0.04). Median survival from the time of AIDS diagnosis was 5 months which did not change significantly during the study period (P = 0.38). Patients (n = 42) presenting with opportunistic infections other than mycobacterial disease (n = 42), Pneumocystis carinii pneumonia (n = 37) or candidiasis (n = 18), had significantly worse survival patterns (P = 0.001). Patients treated with zidovudine (n = 33) survived significantly longer from time of AIDS diagnosis than those not on zidovudine (n = 185; P = 0.0002). No significant survival differences were observed from time of AIDS diagnosis between those who commenced on zidovudine before developing AIDS (n = 17) and those who were treated with zidovudine since diagnosed with AIDS (n = 16; P = 0.80). During the study period zidovudine was only available through private prescriptions. Survival of Southern Brazilian AIDS patients has not improved: earlier access to HIV-related services and the provision of effective and affordable therapeutic interventions are two measures which could improve future survival patterns.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Americas; Brazil; Demographic Factors; Developing Countries; Diseases; Hiv Infections; Latin America; Mortality; Population; Population Dynamics; Research Report; South America; Treatment; Viral Diseases

Mesh:

Substances:

Year:  1994        PMID: 7948159     DOI: 10.1177/095646249400500410

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  4 in total

Review 1.  Comprehensive health care for people infected with HIV in developing countries.

Authors:  Mari M Kitahata; Mary K Tegger; Edward H Wagner; King K Holmes
Journal:  BMJ       Date:  2002-10-26

2.  Preliminary estimates of human immunodeficiency virus prevalence and incidence among cocaine abusers of Porto Alegre, Brazil.

Authors:  Flavio Pechansky; Lisia von Diemen; Felix Kessler; Vania Hirakata; David Metzger; George E Woody
Journal:  J Urban Health       Date:  2003-03       Impact factor: 3.671

Review 3.  Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.

Authors:  David M Lowe; Molebogeng X Rangaka; Fabiana Gordon; Chris D James; Robert F Miller
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

4.  Survival benefits of antiretroviral therapy in Brazil: a model-based analysis.

Authors:  Paula M Luz; Michael P Girouard; Beatriz Grinsztejn; Kenneth A Freedberg; Valdilea G Veloso; Elena Losina; Claudio J Struchiner; Rachel L MacLean; Robert A Parker; A David Paltiel; Rochelle P Walensky
Journal:  J Int AIDS Soc       Date:  2016-03-29       Impact factor: 5.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.